Merus announces appointment of Jason Avery as Chief Business Officer

19-Jun-2012 - Netherlands

Merus B.V., a biopharmaceutical company focused on multispecific human antibody therapeutics, announced that Jason Avery has been appointed as Chief Business Officer.

With a professional background as Head of Business Development at Affitech A/S and Chief Business Officer at Cambridge Antibody Technology, Jason Avery brings extensive industry experience to Merus.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances